{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Others > CarbimazoleCAS：22232-54-8
Molecular Formula：C7H10N2O2S
Molecular Weight：186.23
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 22232-54-8 |
| Name | Carbimazole |
| Molecular Formula | C7H10N2O2S |
| Molecular Weight | 186.23 |
| Solubility | Soluble in DMSO ≥5mg/mL(Need ultrasonic) |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 244-854-4 |
| MDL | MFCD00027421 |
| SMILES | O=C(N1C=CN(C)C1=S)OCC |
| InChIKey | CFOYWRHIYXMDOT-UHFFFAOYSA-N |
| InChI | InChI=1S/C7H10N2O2S/c1-3-11-7(10)9-5-4-8(2)6(9)12/h4-5H,3H2,1-2H3 |
| PubChem CID | 31072 |
| Target Point | Others |
| Passage | Others |
| Background | It is an imidazole anti-thyroid compound that can be used in the research of Graves disease. |
| Biological Activity | Carbimazole是一种有效的甲状腺激素抑制剂。它被认为是一种前体药物，因为它被人体吸收后转化为甲巯咪唑，产生抗甲状腺作用，作用于抗甲亢(过度产生甲状腺激素)和甲状腺毒症(甲状腺炎症)。[1] |
| Data Literature Source | [1] Taurog A，et al. Endocrinology，1976，98(4)，1031-1046. [2] Magnusson RP，et al. J Biol Chem，1984，259(1)，197-205. |
| Unit | Bottle |
| Specification | 500mg 1g |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
